{"id":168,"date":"2011-06-09T19:24:58","date_gmt":"2011-06-09T19:24:58","guid":{"rendered":"https:\/\/blogs.bmj.com\/jmg\/?p=168"},"modified":"2026-02-25T21:06:03","modified_gmt":"2026-02-25T21:06:03","slug":"predicting-pten-mutations-an-evaluation-of-cowden-syndrome-and-bannayan%e2%80%93riley%e2%80%93ruvalcaba-syndrome-clinical-features","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/jmg\/2011\/06\/09\/predicting-pten-mutations-an-evaluation-of-cowden-syndrome-and-bannayan%e2%80%93riley%e2%80%93ruvalcaba-syndrome-clinical-features\/","title":{"rendered":"Predicting PTEN mutations: an evaluation of Cowden syndrome and Bannayan\u2013Riley\u2013Ruvalcaba syndrome clinical features (Contributed by Rob Pilarski)"},"content":{"rendered":"

Cowden syndrome (CS) is an important hereditary cancer syndrome, is caused by mutations in the PTEN gene, which causes significantly increased risks for breast, thyroid, uterine and perhaps colon cancers.\u00a0 Since 1996 the clinical diagnosis of CS has been based upon criteria established by a research consortium. These criteria, however, have not been rigorously examined in large cohorts. We reviewed the clinical features in a group of 172 patients with PTEN mutations and found significant differences from the reported frequencies of several features. We also found that the “Consortium” criteria missed many patients who were found to have PTEN mutations. Conversely, many patients with PTEN mutations did not meet the Consortium criteria. This argues for a re-evaluation of the criteria widely used to diagnose CS. (http:\/\/jmg.bmj.com\/content\/early\/2011\/06\/08\/jmg.2011.088807.abstract?papetoc<\/a> )<\/p>\n","protected":false},"excerpt":{"rendered":"

Cowden syndrome (CS) is an important hereditary cancer syndrome, is caused by mutations in the PTEN gene, which causes significantly increased risks for breast, thyroid, uterine and perhaps colon cancers.\u00a0 Since 1996 the clinical diagnosis of CS has been based upon criteria established by a research consortium. These criteria, however, have not been rigorously examined […]<\/p>\n

Read More…<\/a><\/p>\n","protected":false},"author":123,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-168","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"yoast_head":"\nPredicting PTEN mutations: an evaluation of Cowden syndrome and Bannayan\u2013Riley\u2013Ruvalcaba syndrome clinical features (Contributed by Rob Pilarski) - JMG Contact blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.bmj.com\/jmg\/2011\/06\/09\/predicting-pten-mutations-an-evaluation-of-cowden-syndrome-and-bannayan\u2013riley\u2013ruvalcaba-syndrome-clinical-features\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Predicting PTEN mutations: an evaluation of Cowden syndrome and Bannayan\u2013Riley\u2013Ruvalcaba syndrome clinical features (Contributed by Rob Pilarski) - JMG Contact blog\" \/>\n<meta property=\"og:description\" content=\"Cowden syndrome (CS) is an important hereditary cancer syndrome, is caused by mutations in the PTEN gene, which causes significantly increased risks for breast, thyroid, uterine and perhaps colon cancers.\u00a0 Since 1996 the clinical diagnosis of CS has been based upon criteria established by a research consortium. These criteria, however, have not been rigorously examined [...]Read More...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.bmj.com\/jmg\/2011\/06\/09\/predicting-pten-mutations-an-evaluation-of-cowden-syndrome-and-bannayan\u2013riley\u2013ruvalcaba-syndrome-clinical-features\/\" \/>\n<meta property=\"og:site_name\" content=\"JMG Contact blog\" \/>\n<meta property=\"article:published_time\" content=\"2011-06-09T19:24:58+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-25T21:06:03+00:00\" \/>\n<meta name=\"author\" content=\"hqqu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@HuiQiQu\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"hqqu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2011\\\/06\\\/09\\\/predicting-pten-mutations-an-evaluation-of-cowden-syndrome-and-bannayan%e2%80%93riley%e2%80%93ruvalcaba-syndrome-clinical-features\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2011\\\/06\\\/09\\\/predicting-pten-mutations-an-evaluation-of-cowden-syndrome-and-bannayan%e2%80%93riley%e2%80%93ruvalcaba-syndrome-clinical-features\\\/\"},\"author\":{\"name\":\"hqqu\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/person\\\/be0250f8d5b52412c3e7c222dabd591b\"},\"headline\":\"Predicting PTEN mutations: an evaluation of Cowden syndrome and Bannayan\u2013Riley\u2013Ruvalcaba syndrome clinical features (Contributed by Rob Pilarski)\",\"datePublished\":\"2011-06-09T19:24:58+00:00\",\"dateModified\":\"2026-02-25T21:06:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2011\\\/06\\\/09\\\/predicting-pten-mutations-an-evaluation-of-cowden-syndrome-and-bannayan%e2%80%93riley%e2%80%93ruvalcaba-syndrome-clinical-features\\\/\"},\"wordCount\":151,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2011\\\/06\\\/09\\\/predicting-pten-mutations-an-evaluation-of-cowden-syndrome-and-bannayan%e2%80%93riley%e2%80%93ruvalcaba-syndrome-clinical-features\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2011\\\/06\\\/09\\\/predicting-pten-mutations-an-evaluation-of-cowden-syndrome-and-bannayan%e2%80%93riley%e2%80%93ruvalcaba-syndrome-clinical-features\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2011\\\/06\\\/09\\\/predicting-pten-mutations-an-evaluation-of-cowden-syndrome-and-bannayan%e2%80%93riley%e2%80%93ruvalcaba-syndrome-clinical-features\\\/\",\"name\":\"Predicting PTEN mutations: an evaluation of Cowden syndrome and Bannayan\u2013Riley\u2013Ruvalcaba syndrome clinical features (Contributed by Rob Pilarski) - JMG Contact blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#website\"},\"datePublished\":\"2011-06-09T19:24:58+00:00\",\"dateModified\":\"2026-02-25T21:06:03+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2011\\\/06\\\/09\\\/predicting-pten-mutations-an-evaluation-of-cowden-syndrome-and-bannayan%e2%80%93riley%e2%80%93ruvalcaba-syndrome-clinical-features\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2011\\\/06\\\/09\\\/predicting-pten-mutations-an-evaluation-of-cowden-syndrome-and-bannayan%e2%80%93riley%e2%80%93ruvalcaba-syndrome-clinical-features\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2011\\\/06\\\/09\\\/predicting-pten-mutations-an-evaluation-of-cowden-syndrome-and-bannayan%e2%80%93riley%e2%80%93ruvalcaba-syndrome-clinical-features\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Predicting PTEN mutations: an evaluation of Cowden syndrome and Bannayan\u2013Riley\u2013Ruvalcaba syndrome clinical features (Contributed by Rob Pilarski)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#website\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\",\"name\":\"JMG Contact blog\",\"description\":\"JMG Contact blog\",\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\",\"name\":\"JMG Contact blog\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2017\\\/10\\\/blog-logo-jmg.png\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2017\\\/10\\\/blog-logo-jmg.png\",\"width\":300,\"height\":34,\"caption\":\"JMG Contact blog\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/person\\\/be0250f8d5b52412c3e7c222dabd591b\",\"name\":\"hqqu\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"caption\":\"hqqu\"},\"description\":\"Huiqi Qu has a background as a physician trained in internal medicine and a PhD in Experimental Medicine (Endocrinology). His research applies human genetics and multi-omics to complex and pediatric diseases, including GWAS, polygenic risk scores (PRS), single-cell transcriptomics, and integrative genomics to support precision medicine and clinical translation.\",\"sameAs\":[\"https:\\\/\\\/x.com\\\/HuiQiQu\"],\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/author\\\/hqiqu\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Predicting PTEN mutations: an evaluation of Cowden syndrome and Bannayan\u2013Riley\u2013Ruvalcaba syndrome clinical features (Contributed by Rob Pilarski) - JMG Contact blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.bmj.com\/jmg\/2011\/06\/09\/predicting-pten-mutations-an-evaluation-of-cowden-syndrome-and-bannayan\u2013riley\u2013ruvalcaba-syndrome-clinical-features\/","og_locale":"en_US","og_type":"article","og_title":"Predicting PTEN mutations: an evaluation of Cowden syndrome and Bannayan\u2013Riley\u2013Ruvalcaba syndrome clinical features (Contributed by Rob Pilarski) - JMG Contact blog","og_description":"Cowden syndrome (CS) is an important hereditary cancer syndrome, is caused by mutations in the PTEN gene, which causes significantly increased risks for breast, thyroid, uterine and perhaps colon cancers.\u00a0 Since 1996 the clinical diagnosis of CS has been based upon criteria established by a research consortium. These criteria, however, have not been rigorously examined [...]Read More...","og_url":"https:\/\/blogs.bmj.com\/jmg\/2011\/06\/09\/predicting-pten-mutations-an-evaluation-of-cowden-syndrome-and-bannayan\u2013riley\u2013ruvalcaba-syndrome-clinical-features\/","og_site_name":"JMG Contact blog","article_published_time":"2011-06-09T19:24:58+00:00","article_modified_time":"2026-02-25T21:06:03+00:00","author":"hqqu","twitter_card":"summary_large_image","twitter_creator":"@HuiQiQu","twitter_misc":{"Written by":"hqqu","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.bmj.com\/jmg\/2011\/06\/09\/predicting-pten-mutations-an-evaluation-of-cowden-syndrome-and-bannayan%e2%80%93riley%e2%80%93ruvalcaba-syndrome-clinical-features\/#article","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2011\/06\/09\/predicting-pten-mutations-an-evaluation-of-cowden-syndrome-and-bannayan%e2%80%93riley%e2%80%93ruvalcaba-syndrome-clinical-features\/"},"author":{"name":"hqqu","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/person\/be0250f8d5b52412c3e7c222dabd591b"},"headline":"Predicting PTEN mutations: an evaluation of Cowden syndrome and Bannayan\u2013Riley\u2013Ruvalcaba syndrome clinical features (Contributed by Rob Pilarski)","datePublished":"2011-06-09T19:24:58+00:00","dateModified":"2026-02-25T21:06:03+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2011\/06\/09\/predicting-pten-mutations-an-evaluation-of-cowden-syndrome-and-bannayan%e2%80%93riley%e2%80%93ruvalcaba-syndrome-clinical-features\/"},"wordCount":151,"commentCount":0,"publisher":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#organization"},"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/blogs.bmj.com\/jmg\/2011\/06\/09\/predicting-pten-mutations-an-evaluation-of-cowden-syndrome-and-bannayan%e2%80%93riley%e2%80%93ruvalcaba-syndrome-clinical-features\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/blogs.bmj.com\/jmg\/2011\/06\/09\/predicting-pten-mutations-an-evaluation-of-cowden-syndrome-and-bannayan%e2%80%93riley%e2%80%93ruvalcaba-syndrome-clinical-features\/","url":"https:\/\/blogs.bmj.com\/jmg\/2011\/06\/09\/predicting-pten-mutations-an-evaluation-of-cowden-syndrome-and-bannayan%e2%80%93riley%e2%80%93ruvalcaba-syndrome-clinical-features\/","name":"Predicting PTEN mutations: an evaluation of Cowden syndrome and Bannayan\u2013Riley\u2013Ruvalcaba syndrome clinical features (Contributed by Rob Pilarski) - JMG Contact blog","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#website"},"datePublished":"2011-06-09T19:24:58+00:00","dateModified":"2026-02-25T21:06:03+00:00","breadcrumb":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2011\/06\/09\/predicting-pten-mutations-an-evaluation-of-cowden-syndrome-and-bannayan%e2%80%93riley%e2%80%93ruvalcaba-syndrome-clinical-features\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.bmj.com\/jmg\/2011\/06\/09\/predicting-pten-mutations-an-evaluation-of-cowden-syndrome-and-bannayan%e2%80%93riley%e2%80%93ruvalcaba-syndrome-clinical-features\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.bmj.com\/jmg\/2011\/06\/09\/predicting-pten-mutations-an-evaluation-of-cowden-syndrome-and-bannayan%e2%80%93riley%e2%80%93ruvalcaba-syndrome-clinical-features\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.bmj.com\/jmg\/"},{"@type":"ListItem","position":2,"name":"Predicting PTEN mutations: an evaluation of Cowden syndrome and Bannayan\u2013Riley\u2013Ruvalcaba syndrome clinical features (Contributed by Rob Pilarski)"}]},{"@type":"WebSite","@id":"https:\/\/blogs.bmj.com\/jmg\/#website","url":"https:\/\/blogs.bmj.com\/jmg\/","name":"JMG Contact blog","description":"JMG Contact blog","publisher":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.bmj.com\/jmg\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blogs.bmj.com\/jmg\/#organization","name":"JMG Contact blog","url":"https:\/\/blogs.bmj.com\/jmg\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/logo\/image\/","url":"https:\/\/blogs.bmj.com\/jmg\/files\/2017\/10\/blog-logo-jmg.png","contentUrl":"https:\/\/blogs.bmj.com\/jmg\/files\/2017\/10\/blog-logo-jmg.png","width":300,"height":34,"caption":"JMG Contact blog"},"image":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/person\/be0250f8d5b52412c3e7c222dabd591b","name":"hqqu","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","caption":"hqqu"},"description":"Huiqi Qu has a background as a physician trained in internal medicine and a PhD in Experimental Medicine (Endocrinology). His research applies human genetics and multi-omics to complex and pediatric diseases, including GWAS, polygenic risk scores (PRS), single-cell transcriptomics, and integrative genomics to support precision medicine and clinical translation.","sameAs":["https:\/\/x.com\/HuiQiQu"],"url":"https:\/\/blogs.bmj.com\/jmg\/author\/hqiqu\/"}]}},"_links":{"self":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts\/168","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/users\/123"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/comments?post=168"}],"version-history":[{"count":0,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts\/168\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/media?parent=168"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/categories?post=168"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/tags?post=168"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}